Annual EBITDA
-$15.72 M
+$6.39 M+28.91%
December 1, 2023
Summary
- As of February 8, 2025, QNTM annual EBITDA is -$15.72 million, with the most recent change of +$6.39 million (+28.91%) on December 1, 2023.
- During the last 3 years, QNTM annual EBITDA has risen by +$8.59 million (+35.34%).
- QNTM annual EBITDA is now -80951.55% below its all-time high of -$19.40 thousand, reached on August 1, 2017.
Performance
QNTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.88 M
-$676.80 K-21.10%
September 1, 2024
Summary
- As of February 8, 2025, QNTM quarterly EBITDA is -$3.88 million, with the most recent change of -$676.80 thousand (-21.10%) on September 1, 2024.
- Over the past year, QNTM quarterly EBITDA has stayed the same.
- QNTM quarterly EBITDA is now -228.69% below its all-time high of $3.02 million, reached on September 1, 2018.
Performance
QNTM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.58 M
-$1.23 M-13.17%
September 1, 2024
Summary
- As of February 8, 2025, QNTM TTM EBITDA is -$10.58 million, with the most recent change of -$1.23 million (-13.17%) on September 1, 2024.
- Over the past year, QNTM TTM EBITDA has stayed the same.
- QNTM TTM EBITDA is now -140961.33% below its all-time high of -$7500.00, reached on May 1, 2016.
Performance
QNTM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
QNTM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.9% | 0.0% | 0.0% |
| 3 y3 years | +35.3% | +15.7% | +61.9% |
| 5 y5 years | +4.9% | -35.7% | +65.2% |
QNTM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.3% | -154.0% | +56.0% | -13.2% | +64.5% |
| 5 y | 5-year | at high | +50.8% | -154.0% | +67.0% | -13.2% | +72.4% |
| alltime | all time | <-9999.0% | +50.8% | -228.7% | +74.5% | <-9999.0% | +72.4% |
Quantum BioPharma Ltd EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.88 M(+21.1%) | -$10.58 M(+13.2%) |
| Jun 2024 | - | -$3.21 M(+63.7%) | -$9.35 M(-11.2%) |
| Mar 2024 | - | -$1.96 M(+28.1%) | -$10.52 M(-39.5%) |
| Dec 2023 | -$15.72 M(-28.9%) | -$1.53 M(-42.4%) | -$17.39 M(-16.6%) |
| Sep 2023 | - | -$2.65 M(-39.5%) | -$20.85 M(-13.7%) |
| Jun 2023 | - | -$4.38 M(-50.3%) | -$24.17 M(-9.1%) |
| Mar 2023 | - | -$8.83 M(+76.9%) | -$26.60 M(+20.3%) |
| Dec 2022 | -$22.12 M(-25.8%) | -$4.99 M(-16.4%) | -$22.12 M(-0.2%) |
| Sep 2022 | - | -$5.97 M(-12.5%) | -$22.15 M(+6.5%) |
| Jun 2022 | - | -$6.82 M(+56.9%) | -$20.79 M(-19.2%) |
| Mar 2022 | - | -$4.34 M(-13.6%) | -$25.73 M(-13.7%) |
| Dec 2021 | -$29.82 M(+22.6%) | -$5.03 M(+9.1%) | -$29.82 M(+7.4%) |
| Sep 2021 | - | -$4.61 M(-60.8%) | -$27.76 M(-19.6%) |
| Jun 2021 | - | -$11.75 M(+39.3%) | -$34.53 M(+34.7%) |
| Mar 2021 | - | -$8.44 M(+184.7%) | -$25.64 M(+5.4%) |
| Dec 2020 | -$24.32 M | -$2.96 M(-73.9%) | -$24.32 M(-23.4%) |
| Sep 2020 | - | -$11.37 M(+297.3%) | -$31.72 M(+4.4%) |
| Jun 2020 | - | -$2.86 M(-59.8%) | -$30.39 M(-20.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$7.12 M(-31.4%) | -$38.28 M(+19.5%) |
| Dec 2019 | -$31.98 M(+93.4%) | -$10.37 M(+3.3%) | -$32.04 M(-13.1%) |
| Sep 2019 | - | -$10.04 M(-6.5%) | -$36.88 M(+54.9%) |
| Jun 2019 | - | -$10.75 M(+1129.4%) | -$23.81 M(+49.1%) |
| Mar 2019 | - | -$874.10 K(-94.3%) | -$15.97 M(-10.3%) |
| Dec 2018 | -$16.54 M(+490.1%) | -$15.21 M(-604.0%) | -$17.81 M(+584.8%) |
| Sep 2018 | - | $3.02 M(-203.9%) | -$2.60 M(-53.8%) |
| Jun 2018 | - | -$2.90 M(+8.8%) | -$5.62 M(+106.6%) |
| Mar 2018 | - | -$2.67 M(+6727.6%) | -$2.72 M(+4989.9%) |
| Feb 2018 | - | -$39.10 K(+666.7%) | -$53.50 K(+123.8%) |
| Dec 2017 | -$2.80 M(>+9900.0%) | - | - |
| Nov 2017 | - | -$5100.00(-16.4%) | -$23.90 K(+21.9%) |
| Aug 2017 | -$19.40 K(-34.5%) | -$6100.00(+90.6%) | -$19.60 K(-27.4%) |
| May 2017 | - | -$3200.00(-66.3%) | -$27.00 K(-13.7%) |
| Feb 2017 | - | -$9500.00(+1087.5%) | -$31.30 K(+43.6%) |
| Nov 2016 | - | -$800.00(-94.1%) | -$21.80 K(+3.8%) |
| Aug 2016 | -$29.60 K(-9.8%) | -$13.50 K(+80.0%) | -$21.00 K(+180.0%) |
| May 2016 | - | -$7500.00 | -$7500.00 |
| Aug 2015 | -$32.80 K | - | - |
FAQ
- What is Quantum BioPharma Ltd annual EBITDA?
- What is the all time high annual EBITDA for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd annual EBITDA year-on-year change?
- What is Quantum BioPharma Ltd quarterly EBITDA?
- What is the all time high quarterly EBITDA for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd quarterly EBITDA year-on-year change?
- What is Quantum BioPharma Ltd TTM EBITDA?
- What is the all time high TTM EBITDA for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd TTM EBITDA year-on-year change?
What is Quantum BioPharma Ltd annual EBITDA?
The current annual EBITDA of QNTM is -$15.72 M
What is the all time high annual EBITDA for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high annual EBITDA is -$19.40 K
What is Quantum BioPharma Ltd annual EBITDA year-on-year change?
Over the past year, QNTM annual EBITDA has changed by +$6.39 M (+28.91%)
What is Quantum BioPharma Ltd quarterly EBITDA?
The current quarterly EBITDA of QNTM is -$3.88 M
What is the all time high quarterly EBITDA for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high quarterly EBITDA is $3.02 M
What is Quantum BioPharma Ltd quarterly EBITDA year-on-year change?
Over the past year, QNTM quarterly EBITDA has changed by $0.00 (0.00%)
What is Quantum BioPharma Ltd TTM EBITDA?
The current TTM EBITDA of QNTM is -$10.58 M
What is the all time high TTM EBITDA for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high TTM EBITDA is -$7500.00
What is Quantum BioPharma Ltd TTM EBITDA year-on-year change?
Over the past year, QNTM TTM EBITDA has changed by $0.00 (0.00%)